The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bobko S.I.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Clinical experience of combination glucocorticosteroids use for the treatment of psoriasis and seborrheic dermatitis in adults

Authors:

Bobko S.I.

More about the authors

Read: 512 times


To cite this article:

Bobko SI. Clinical experience of combination glucocorticosteroids use for the treatment of psoriasis and seborrheic dermatitis in adults. Russian Journal of Clinical Dermatology and Venereology. 2025;24(5):692‑697. (In Russ.)
https://doi.org/10.17116/klinderma202524051692

Recommended articles:
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177
Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xero­sis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):178-184
Historical aspe­cts and prospects of psoriasis treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):284-292
Key specific tools for asse­ssment of life quality of patients with psoriasis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):319-325
Psychodermatological aspe­cts of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):403-411
New approach to clinical evaluation of nail lesions in psoriasis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):453-460
Unde­restimated itching symptom in psoriasis: diagnostic limi­tations and correction paths. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):675-682

References:

  1. Potekaev NN, Kruglova LS. Psoriaticheskaya bolezn’. M.: Gruppa MDV; 2014. (In Russ.).
  2. Raznatovskiy KI, Terletskiy OV. Psoriaticheskaya bolezn’. Diagnostika, terapiya, profilaktika. M.: GEOTAR-Media; 2017. (In Russ.).
  3. Blome C, Gosau, Radtke MA, Reich K, Rustenbach SJ, Spehr C, Thaci D, Augustin M. Patients-relevant treatment goals in psoriasis. Arch Dermatol Res. 2016;308(2):69-78. 
  4. Sobell JM, Foley P, Toth D, Mrowietz U, Girolomoni G, Goncalves J, Day RM, Chen R, Yosipovitch G. Effects of Apremilast on Pruritus and skin discomfort/pain correlate with improvements in quality of life in patients with moderate to severe plague psoriasis. Acta DermVenereol. 2016;96:514-520. 
  5. Hrehorow E, Salomon J, Matusiak L, Reich A, Szepietowski JC. Patients with psoriasis feel stigmatized. Acta DermVenereol. 2012;92:67-72. 
  6. Lewis-Beck C, Abouzaid S, Xie L, Baser O, Kim E. Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling. PatientPreferAdherence. 2013;7:199-205. 
  7. Parry ME, Sharpe GR. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol. 1998;139(2):254-263. 
  8. Matushevskaya EV, Vladimirova EV, Matushevskaya YuI, Averbukh EA, Shatalova AYu. Topical therapy of psoriasis. Analysis of clinical cases. Medical Council. 2021;8:13-18. (In Russ.).
  9. Shperling NV, Shperling MI, Chaplygin AV, Chaplygina NV. The use of salicylic acid and glucocorticosteroids in vulgar psoriasis. Medical Council. 2023;17(23):337-342. (In Russ.). https://doi.org/10.21518/ms2023-449
  10. Kovaleva YuS, Komkina NG. Psoriasis of the scalp — pathogenetic therapy. Medical Council. 2024;18(13):69-76. (In Russ.). https://doi.org/10.21518/ms2024-189
  11. Tereshchenko GP, Tereshchenko OV, Ostretsova MN, Bobrov MA, Alkhaffar S. Papulosquamous dermatoses of the scalp: key aspects of differential diagnosis and treatment. Medical Council. 2024;18(14):124-132. (In Russ.). https://doi.org/10.21518/ms2024-288
  12. Arsen’eva AA, Orlov EV, Pakhomova YuM. The possibilities of using a combination of glucocorticosteroid and salicylic acid in a solution format for psoriasis vulgaris. Medical Council. 2024;18(23):199-204. (In Russ.). https://doi.org/10.21518/ms2024-434
  13. Tlish MM, Kuznetsova TG, Shavilova ME, Psavok FA. External therapy of  psoriasis of the scalp: from relief of exacerbations to stable remission. Medical Council. 2025;19(2):91-96. (In Russ.). https://doi.org/10.21518/ms2025-068
  14. Sogomonyan LM, Chaplygin AV, Chaplygina NV, Shperling NV, Shperling MI. The use of systemic cytoprotective therapy in combination with combined local therapy based on salicylic acid and glucocorticosteroids in vulgar psoriasis. Russian Journal of Clinical Dermatology and Venereology. 2024;2:168-172. (In Russ.). https://doi.org/10.17116/klinderma202423021168
  15. Jenerowicz D, Kaznowska J, Bartkiewicz P, Sadowska-Przytocka A, Szymkowia M, Adamski Z, Czarnecka-Operacz M. Contemporary treatment patterns in plaque proriasis and psoriatic arthritis. Postepy Dermatol Allergol. 2021;38(2):80-84.  https://doi.org/10.5114/ada.2019.91502
  16. Lebwohl The role of salicylic acid in the treatment of psoriasis. Int J Dermatol. 1999;38(1):16-24. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.